CARLOS
MACAYA MIGUEL
Profesor emérito
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (7)
2021
-
Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients
Health Care Management Science, Vol. 24, Núm. 2, pp. 339-355
2010
-
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial
The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
Circulation, Vol. 121, Núm. 10, pp. 1176-1187
2003
-
IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: A prospective, angiography-based evaluation
Atherosclerosis, Vol. 171, Núm. 2, pp. 259-264
-
Lipid metabolism and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: Role of cholesteryl ester transfer protein and paraoxonase/arylesterase
Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 6, pp. 1202-1207
2002
-
Multi-locus interactions predict risk for post-PTCA restenosis: An approach to the genetic analysis of common complex disease
Pharmacogenomics Journal, Vol. 2, Núm. 3, pp. 197-201
2001
-
ACE D/I polymorphism and incidence of post-PTCA restenosis: A prospective, angiography-based evaluation
Hypertension, Vol. 37, Núm. 3, pp. 851-855